HomeADPT • NASDAQ
add
Adaptive Biotechnologies Corp
Previous close
$7.99
Day range
$7.57 - $8.15
Year range
$2.28 - $8.33
Market cap
1.13B USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 46.44M | 22.46% |
Operating expense | 38.24M | -6.73% |
Net income | -32.07M | 36.24% |
Net profit margin | -69.07 | 47.93% |
Earnings per share | -0.22 | 38.26% |
EBITDA | -28.04M | 37.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 243.33M | -34.44% |
Total assets | 558.51M | -22.18% |
Total liabilities | 334.93M | -5.93% |
Total equity | 223.57M | — |
Shares outstanding | 147.58M | — |
Price to book | 5.26 | — |
Return on assets | -14.27% | — |
Return on capital | -17.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -32.07M | 36.24% |
Cash from operations | -27.06M | 42.03% |
Cash from investing | 5.29M | -79.77% |
Cash from financing | 40.00K | 135.29% |
Net change in cash | -21.74M | -5.89% |
Free cash flow | -10.52M | 59.07% |
About
CEO
Founded
2009
Headquarters
Website
Employees
709
